NO20025402D0 - Modifiserte ES-celler og ES-spesifikt gen - Google Patents
Modifiserte ES-celler og ES-spesifikt genInfo
- Publication number
- NO20025402D0 NO20025402D0 NO20025402A NO20025402A NO20025402D0 NO 20025402 D0 NO20025402 D0 NO 20025402D0 NO 20025402 A NO20025402 A NO 20025402A NO 20025402 A NO20025402 A NO 20025402A NO 20025402 D0 NO20025402 D0 NO 20025402D0
- Authority
- NO
- Norway
- Prior art keywords
- cells
- modified
- specific gene
- pluripotent
- nucleic acid
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 241000271566 Aves Species 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Husbandry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0006029A FR2808803B1 (fr) | 2000-05-11 | 2000-05-11 | Cellules es modifiees et gene specifique de cellules es |
PCT/FR2001/001207 WO2001085938A1 (fr) | 2000-05-11 | 2001-04-19 | Cellules es modifiees et gene specifique de cellules es |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20025402D0 true NO20025402D0 (no) | 2002-11-11 |
NO20025402L NO20025402L (no) | 2003-01-08 |
NO331814B1 NO331814B1 (no) | 2012-04-10 |
Family
ID=8850125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025402A NO331814B1 (no) | 2000-05-11 | 2002-11-11 | Renset eller isolert nukleinsyre, isolert polypeptid, klonings- og/eller ekspresjonsvektor omfattende nukleinsyren, vertscelle, differensiert ES-celle, dyr omfattende cellene, anvendelse av nukleinsyren for pavisning og/eller amplifisering av nukleinsyresekvenser, som sens- eller antisensoligonukleotid, og fremstilling av rekombinant polypeptid, monoklonalt eller polyklonalt antistoff som selektivt binder polypeptidet, fremgangsmate for pavisning av polypeptidet, analysesett til bruk i fremgangsmaten, fremgangsmate for pavisning av pluripotent natur for ES-fuglecelle, fremgangsmate for klassifisering av fugl, DNA-chip, proteinchip, fremgangsmate for pavisning av polypeptidet i matprove, fremgangsmate for analyse av om forbindelse eller medium kan indusere differensiering av pluripotent celle, eller gjenopprette pluripotent natur, og anvendelse av nukleinsyren som promoter for gen for uttrykking av genet i pluripotent fuglecelle. |
Country Status (14)
Country | Link |
---|---|
US (2) | US20040072169A1 (no) |
EP (1) | EP1280898B1 (no) |
JP (1) | JP2004515212A (no) |
AT (1) | ATE498011T1 (no) |
AU (2) | AU2001254885B2 (no) |
BR (1) | BR0110764A (no) |
CA (1) | CA2408732A1 (no) |
DE (1) | DE60144015D1 (no) |
DK (1) | DK1280898T3 (no) |
ES (1) | ES2358731T3 (no) |
FR (1) | FR2808803B1 (no) |
NO (1) | NO331814B1 (no) |
NZ (1) | NZ522547A (no) |
WO (1) | WO2001085938A1 (no) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2808803B1 (fr) * | 2000-05-11 | 2004-12-10 | Agronomique Inst Nat Rech | Cellules es modifiees et gene specifique de cellules es |
JP4183614B2 (ja) * | 2001-05-31 | 2008-11-19 | 伸弥 山中 | Es細胞特異的発現遺伝子 |
PL1951296T5 (pl) | 2005-11-01 | 2015-06-30 | Seqirus Uk Ltd | Szczepionki wirusowe otrzymane z komórek o niskim poziomie pozostałości DNA komórkowego poprzez traktowanie beta-propiolaktonem |
CA2628206A1 (en) | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics S.R.L. | Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant |
US20110180430A1 (en) | 2005-11-04 | 2011-07-28 | Novartis Vaccines And Diagnostics Srl | Adjuvanted influenza vaccines including cytokine-inducing agents |
CA2628158C (en) | 2005-11-04 | 2015-12-15 | Novartis Vaccines And Diagnostics S.R.L. | Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines |
AU2006310339B2 (en) | 2005-11-04 | 2013-01-10 | Novartis Ag | Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
EP3714900A1 (en) | 2005-11-04 | 2020-09-30 | Seqirus UK Limited | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
BR122019013216B8 (pt) | 2006-01-27 | 2021-07-27 | Seqirus Uk Ltd | ensaio imunológico para análise de uma vacina contra influenza |
FR2898909A1 (fr) | 2006-03-24 | 2007-09-28 | Agronomique Inst Nat Rech | Combinaison de marqueurs de cellules aviaires |
CA2646349A1 (en) | 2006-03-24 | 2007-10-04 | Novartis Vaccines And Diagnostics Gmbh & Co Kg | Storage of influenza vaccines without refrigeration |
GB0614460D0 (en) | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
CN101553252A (zh) | 2006-12-06 | 2009-10-07 | 诺华有限公司 | 包含来自于四株流感病毒的抗原的疫苗 |
AU2008269439B2 (en) | 2007-06-27 | 2013-12-19 | Novartis Ag | Low-additive influenza vaccines |
GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
AU2009227674C1 (en) | 2008-03-18 | 2015-01-29 | Seqirus UK Limited | Improvements in preparation of influenza virus vaccine antigens |
WO2010079081A1 (en) | 2009-01-07 | 2010-07-15 | Glaxosmithkline Biologicals S.A. | Methods for recovering a virus or a viral antigen produced by cell culture |
US20110293660A1 (en) | 2009-02-06 | 2011-12-01 | Bruno Rene Andre | Novel method |
KR20110132373A (ko) | 2009-02-10 | 2011-12-07 | 노파르티스 아게 | 유행병-연관 주에 대한 인플루엔자 백신 요법 |
AU2010212548A1 (en) | 2009-02-10 | 2011-09-15 | Novartis Ag | Influenza vaccines with increased amounts of H3 antigen |
DK2396032T3 (en) | 2009-02-10 | 2016-12-19 | Seqirus Uk Ltd | Influenza vaccines with reduced amounts of squalene |
EP2424565A1 (en) | 2009-04-27 | 2012-03-07 | Novartis AG | Adjuvanted vaccines for protecting against influenza |
CA2773637A1 (en) | 2009-09-10 | 2011-03-17 | Novartis Ag | Combination vaccines against respiratory tract diseases |
US20120309056A1 (en) | 2010-02-04 | 2012-12-06 | Leon Arnaud | Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells |
WO2011110955A2 (en) | 2010-03-08 | 2011-09-15 | Novartis Ag | Methods of testing for intracellular pathogens |
ES2562818T3 (es) | 2010-05-03 | 2016-03-08 | Glaxosmithkline Biologicals S.A. | Procedimiento de inactivación del virus de la gripe |
EP2566323A2 (en) | 2010-05-06 | 2013-03-13 | Novartis AG | Organic peroxide compounds for microorganism inactivation |
AU2011254204B2 (en) | 2010-05-21 | 2015-08-20 | Seqirus UK Limited | Influenza virus reassortment method |
JP5976639B2 (ja) | 2010-06-01 | 2016-08-23 | ノバルティス アーゲー | インフルエンザワクチン抗原の濃縮および凍結乾燥 |
AU2011262309B2 (en) | 2010-06-01 | 2015-08-13 | Seqirus UK Limited | Concentration of influenza vaccine antigens without lyophilization |
EP2605792B1 (en) | 2010-08-20 | 2014-12-10 | Novartis AG | Soluble needle arrays for delivery of influenza vaccines |
US20140287402A1 (en) | 2011-06-27 | 2014-09-25 | Valneva | Method for screening cells |
GB201216121D0 (en) | 2012-09-10 | 2012-10-24 | Novartis Ag | Sample quantification by disc centrifugation |
CA2852857A1 (en) | 2011-10-20 | 2013-04-25 | Novartis Ag | Adjuvanted influenza b virus vaccines for pediatric priming |
GB201218195D0 (en) | 2012-10-10 | 2012-11-21 | Istituto Zooprofilattico Sperimentale Delle Venezie | Composition |
US10392603B2 (en) | 2013-08-30 | 2019-08-27 | The Chemo-Sero-Therapeutic Research Institute | Method of viral purification |
US20170369854A1 (en) | 2014-12-16 | 2017-12-28 | Glaxosmithkline Biologicals Sa | A method for a large scale virus purification |
HUE055002T2 (hu) | 2014-12-17 | 2021-10-28 | Fundacion Para La Investig Medica Aplicada | Nukleinsav-konstrukciók és génterápiás vektorok Wilson-kór kezelésében történõ alkalmazásra |
HUE048551T2 (hu) | 2014-12-17 | 2020-08-28 | Fundacion Para La Investig Medica Aplicada | Nukleinsav-szerkezetek és génterápiás vektorok Wilson-kór és egyéb állapotok kezelésében történõ alkalmazásra |
JP2018524323A (ja) | 2015-06-26 | 2018-08-30 | セキラス ユーケー リミテッド | 抗原がマッチしたインフルエンザワクチン |
BR112018000296A2 (pt) | 2015-07-07 | 2018-09-04 | Seqirus UK Limited | ensaios de potência de influenza |
EP3794127A1 (en) | 2018-05-14 | 2021-03-24 | Vivet Therapeutics | Gene therapy vectors comprising s/mar sequences |
EP4223320A3 (en) | 2018-10-12 | 2023-09-13 | Vivet Therapeutics | Codon-optimized transgene for the treatment of progressive familiar intrahepatic cholestasis type 3 (pfic3) |
US20210369870A1 (en) | 2018-11-16 | 2021-12-02 | Encoded Therapeutics, Inc. | Compositions and methods for treating wilson's disease |
JP2022544740A (ja) | 2019-07-02 | 2022-10-21 | フンダシオン・パラ・ラ・インベスティガシオン・メディカ・アプリカダ | cPLA2e誘導剤及びその使用 |
BR112022009545A2 (pt) | 2019-11-18 | 2022-10-11 | Seqirus Pty Ltd | Método para produzir vírus influenza recombinantes |
MX2023000968A (es) | 2020-08-06 | 2023-03-01 | Fundacion Para La Investig Medica Aplicada | Particulas virales para usarse en el tratamiento contra tauopatias tales como enfermedad de alzheimer mediante terapia genica. |
US20230265456A1 (en) | 2020-08-10 | 2023-08-24 | Fundacion Para La Investigacion Medica Aplicada | Gene therapy vector expressing cyp27a1 for the treatment of cerebrotendinous xanthomatosis |
CN116390935A (zh) | 2020-10-09 | 2023-07-04 | Ucb生物制药有限责任公司 | 核酸构建体、病毒载体和病毒颗粒 |
AU2022378524A1 (en) | 2021-10-28 | 2024-05-02 | UCB Biopharma SRL | Nucleic acid constructs, viral vectors and viral particles |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309822B1 (en) * | 1989-06-07 | 2001-10-30 | Affymetrix, Inc. | Method for comparing copy number of nucleic acid sequences |
FR2726003B1 (fr) * | 1994-10-21 | 2002-10-18 | Agronomique Inst Nat Rech | Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires |
EP1117765A2 (en) * | 1998-08-31 | 2001-07-25 | New York University | Stem cells bearing an fgf receptor on the cell surface |
FR2808803B1 (fr) * | 2000-05-11 | 2004-12-10 | Agronomique Inst Nat Rech | Cellules es modifiees et gene specifique de cellules es |
-
2000
- 2000-05-11 FR FR0006029A patent/FR2808803B1/fr not_active Expired - Fee Related
-
2001
- 2001-04-19 CA CA002408732A patent/CA2408732A1/fr not_active Abandoned
- 2001-04-19 JP JP2001582527A patent/JP2004515212A/ja active Pending
- 2001-04-19 DE DE60144015T patent/DE60144015D1/de not_active Expired - Lifetime
- 2001-04-19 BR BR0110764-0A patent/BR0110764A/pt not_active Application Discontinuation
- 2001-04-19 NZ NZ522547A patent/NZ522547A/en not_active IP Right Cessation
- 2001-04-19 AU AU2001254885A patent/AU2001254885B2/en not_active Ceased
- 2001-04-19 AU AU5488501A patent/AU5488501A/xx active Pending
- 2001-04-19 EP EP01928006A patent/EP1280898B1/fr not_active Expired - Lifetime
- 2001-04-19 ES ES01928006T patent/ES2358731T3/es not_active Expired - Lifetime
- 2001-04-19 US US10/275,906 patent/US20040072169A1/en not_active Abandoned
- 2001-04-19 AT AT01928006T patent/ATE498011T1/de not_active IP Right Cessation
- 2001-04-19 WO PCT/FR2001/001207 patent/WO2001085938A1/fr active Application Filing
- 2001-04-19 DK DK01928006.4T patent/DK1280898T3/da active
-
2002
- 2002-11-11 NO NO20025402A patent/NO331814B1/no not_active IP Right Cessation
-
2007
- 2007-11-21 US US11/984,835 patent/US20090151013A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2001254885B2 (en) | 2006-08-10 |
FR2808803B1 (fr) | 2004-12-10 |
NO20025402L (no) | 2003-01-08 |
ATE498011T1 (de) | 2011-02-15 |
WO2001085938A1 (fr) | 2001-11-15 |
AU5488501A (en) | 2001-11-20 |
US20040072169A1 (en) | 2004-04-15 |
DK1280898T3 (da) | 2011-05-16 |
BR0110764A (pt) | 2003-05-06 |
FR2808803A1 (fr) | 2001-11-16 |
ES2358731T3 (es) | 2011-05-13 |
JP2004515212A (ja) | 2004-05-27 |
US20090151013A1 (en) | 2009-06-11 |
EP1280898A1 (fr) | 2003-02-05 |
CA2408732A1 (fr) | 2001-11-15 |
EP1280898B1 (fr) | 2011-02-09 |
NZ522547A (en) | 2006-02-24 |
DE60144015D1 (de) | 2011-03-24 |
NO331814B1 (no) | 2012-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20025402D0 (no) | Modifiserte ES-celler og ES-spesifikt gen | |
WO2003093469A3 (en) | Methods for delivering nucleic acid molecules into cells and assessment thereof | |
WO2006083276A3 (en) | Interferon-alpha polypeptides and conjugates | |
ATE514783T1 (de) | Plasmidsystem zur expression mehrerer gene | |
ATE500323T1 (de) | Subtilisin-variante | |
ATE309536T1 (de) | Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen | |
DK1106696T3 (da) | Proteindeamiderende enzym, mikroorganisme producerende dette, gen kodende derfor, fremgangsmåde til fremstilling af enzymet og anvendelse deraf | |
NO20065084L (no) | Interferon-alfa polypeptider og konjugater | |
HK1102512A1 (en) | Methods and materials using signaling probes | |
DE60213803D1 (en) | Happier mapping | |
WO2002006457A3 (en) | Novel lipase genes | |
ATE345819T1 (de) | Kapsidmodifiziertes rekombinantes adenovirusund verfahren zu dessen anwendung | |
ATE439441T1 (de) | Veränderte, fluoreszierende proteine | |
HUP0203221A2 (hu) | A lignin bioszintézisében résztvevő enzimeket kódoló gének és alkalmazásuk | |
DE50107766D1 (de) | Zweifarbiges fluorimetrisches proteaseassay | |
WO2000053759A8 (en) | Expression of human alpha-fetoprotein in mammalian cells | |
WO2000011168A3 (en) | Genes that regulate hematopoietic blood forming stem cells and uses thereof | |
WO2002064756A3 (en) | Stem cell identification | |
ATE403863T1 (de) | Verfahren zum nachweis von intrazellulären atp und/oder genexpression | |
DE50113417D1 (de) | Zellbindende nukleinsäuremoleküle (aptamere) | |
DK1360306T3 (da) | DNA-sekvens af enzymet phospholipase A1 fra ciliate Tetrahymena og anvendelse heraf | |
ATE446316T1 (de) | Chimere proteine zum targeting von zellen und der induktion von apoptose, und verfahren zu deren verwendung | |
DE60124910D1 (de) | Menschliche twik-8 moleküle und ihre verwendung | |
WO2006063075A3 (en) | Hemipteran octopamine receptor | |
MXPA05008925A (es) | Ciclooxigenasa-3 humana y usos de la misma. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |